Want to see BHVN full AI Analyst Report?
Biohaven Ltd. (BHVN) Ratios
Biohaven Ltd. Ratios
BHVN's free cash flow for Q3 2026 was $-107.03M. For the 2026 fiscal year, BHVN's free cash flow was decreased by $-180.00K and operating cash flow was $-106.85M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 3.18 | 3.49 | 7.98 | 6.52 | 2.26 |
| Quick Ratio | 3.18 | 3.49 | 7.98 | 6.52 | 2.26 |
| Cash Ratio | 1.98 | 0.64 | 4.48 | 2.28 | 1.81 |
| Solvency Ratio | -1.83 | -4.38 | -4.71 | -4.62 | -4.48 |
| Operating Cash Flow Ratio | -5.26 | -3.78 | -5.99 | -3.31 | -3.48 |
| Short-Term Operating Cash Flow Coverage | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Current Asset Value | $ -31.05M | $ 346.80M | $ 357.21M | $ 463.96M | $ 47.45M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.63 | 0.06 | 0.06 | 0.05 | 0.02 |
| Debt-to-Equity Ratio | 5.47 | 0.09 | 0.07 | 0.06 | 0.09 |
| Debt-to-Capital Ratio | 0.85 | 0.08 | 0.07 | 0.06 | 0.09 |
| Long-Term Debt-to-Capital Ratio | 0.82 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 8.67 | 1.45 | 1.20 | 1.23 | 4.10 |
| Debt Service Coverage Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Coverage Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Debt to Market Cap | 0.20 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Debt Per Share | 2.64 | 0.40 | 0.43 | 0.75 | 0.09 |
| Net Debt to EBITDA | -0.08 | 0.07 | 0.51 | 0.30 | 0.33 |
| Profitability Margins | |||||
| Gross Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EBIT Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EBITDA Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Operating Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Pretax Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Net Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Continuous Operations Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Net Income Per EBT | 100.20% | 100.09% | 99.66% | 100.08% | 100.64% |
| EBT Per EBIT | 98.93% | 95.55% | 93.92% | 100.34% | 97.04% |
| Return on Assets (ROA) | -163.66% | -137.61% | -79.53% | -86.17% | -150.50% |
| Return on Equity (ROE) | -1418.85% | -199.89% | -95.37% | -105.85% | -616.29% |
| Return on Capital Employed (ROCE) | -222.16% | -192.05% | -95.25% | -99.33% | -218.62% |
| Return on Invested Capital (ROIC) | -218.41% | -190.48% | -94.25% | -98.81% | -217.67% |
| Return on Tangible Assets | -171.16% | -142.18% | -82.72% | -88.83% | -175.64% |
| Earnings Yield | -60.80% | -24.84% | -13.39% | -91.83% | -81.76% |
| Efficiency Ratios | |||||
| Receivables Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Payables Turnover | 0.36 | 0.00 | 0.00 | 0.00 | 0.00 |
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fixed Asset Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Asset Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Working Capital Turnover Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | -1026.50 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Sales Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Inventory Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Payables Outstanding | 1026.50 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Cycle | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -5.66 | -6.38 | -4.66 | -6.65 | -4.07 |
| Free Cash Flow Per Share | -5.67 | -6.43 | -4.70 | -7.57 | -4.10 |
| Dividend Paid and CapEx Coverage Ratio | -852.36 | -143.85 | -108.83 | -7.25 | -155.48 |
| Capital Expenditure Coverage Ratio | -852.36 | -143.85 | -108.83 | -7.25 | -155.48 |
| Operating Cash Flow Coverage Ratio | -2.14 | -15.92 | -10.74 | -8.86 | -45.07 |
| Operating Cash Flow to Sales Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Free Cash Flow Yield | -50.21% | -17.21% | -10.99% | -54.55% | -56.13% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -1.65 | -4.02 | -7.47 | -1.09 | -1.22 |
| Price-to-Sales (P/S) Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Price-to-Book (P/B) Ratio | 23.33 | 8.05 | 7.12 | 1.15 | 7.54 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -1.99 | -5.81 | -9.10 | -1.83 | -1.78 |
| Price-to-Operating Cash Flow Ratio | -1.99 | -5.85 | -9.19 | -2.09 | -1.79 |
| Price-to-Earnings Growth (PEG) Ratio | 0.06 | -0.06 | 0.14 | -0.01 | -0.02 |
| Enterprise Value Multiple | -1.75 | -3.99 | -6.59 | -0.79 | -0.87 |
| Enterprise Value | 1.27B | 3.35B | 2.83B | 449.73M | 188.69M |
| EV to EBITDA | -1.75 | -3.99 | -6.59 | -0.79 | -0.87 |
| EV to Sales | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EV to Free Cash Flow | -2.08 | -5.70 | -8.45 | -1.33 | -1.29 |
| EV to Operating Cash Flow | -2.08 | -5.74 | -8.53 | -1.51 | -1.29 |
| Tangible Book Value Per Share | 0.30 | 4.42 | 5.73 | 11.60 | 2.08 |
| Shareholders’ Equity Per Share | 0.48 | 4.64 | 6.01 | 12.04 | 0.97 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | -0.00 | -0.00 | 0.00 | -0.00 | -0.01 |
| Revenue Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income Per Share | -6.86 | -9.28 | -5.73 | -12.75 | -5.97 |
| Tax Burden | 1.00 | 1.00 | 1.00 | 1.00 | 1.01 |
| Interest Burden | 1.00 | 1.00 | 0.94 | 1.00 | 0.97 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 0.82 | 0.69 | 0.81 | 0.52 | 0.68 |
Currency in USD